Cargando…

Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination

Various human pathogenic viruses employ envelope glycoproteins for host cell receptor recognition and binding, membrane fusion and viral entry. The spike (S) glycoprotein of betacoronavirus SARS-CoV-2 is a homotrimeric class I fusion protein that exists in a metastable conformation for cleavage by h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sternberg, Ariane, Naujokat, Cord
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336130/ https://www.ncbi.nlm.nih.gov/pubmed/32645344 http://dx.doi.org/10.1016/j.lfs.2020.118056

Ejemplares similares

Candidate drugs against SARS-CoV-2 and COVID-19
por: McKee, Dwight L., et al.
Publicado: (2020)

Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond
por: Lu, Guangwen, et al.
Publicado: (2015)

The spike protein of SARS-CoV — a target for vaccine and therapeutic development
por: Du, Lanying, et al.
Publicado: (2009)

SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
por: Salvatori, Giovanni, et al.
Publicado: (2020)

Structure of SARS-CoV-2 spike protein
por: Zhang, Jun, et al.
Publicado: (2021)

Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia
por: Singh, Santosh Kumar, et al.
Publicado: (2021)

Structure-based study of immune receptors as eligible binding targets of coronavirus SARS-CoV-2 spike protein
por: Mobini, Saeed, et al.
Publicado: (2021)

Elucidating the distinct structural features of the SARS-CoV-2 spike protein fusion domain
por: Birtles, Daniel
Publicado: (2022)

Structural Comparison of the SARS CoV 2 Spike Protein Relative to Other Human-Infecting Coronaviruses
por: Cueno, Marni E., et al.
Publicado: (2021)

MERS-CoV spike protein: Targets for vaccines and therapeutics
por: Wang, Qihui, et al.
Publicado: (2016)

Identification of a SARS-like bat coronavirus that shares structural features with the spike glycoprotein receptor-binding domain of SARS-CoV-2
por: Fraguas Bringas, Conchita, et al.
Publicado: (2020)

SARS-CoV-2 variants – Evolution, spike protein, and vaccines
por: Chen, Kai-Wei K., et al.
Publicado: (2022)

Emergence of SARS‐CoV‐2 spike protein at the vaccination site
por: Beck, Annika, et al.
Publicado: (2023)

Structure of SARS-CoV-2 Spike Glycoprotein for Therapeutic and Preventive Target
por: Hong, Jaewoo, et al.
Publicado: (2021)

Molecular dynamics studies reveal structural and functional features of the SARS‐CoV‐2 spike protein
por: Pipitò, Ludovico, et al.
Publicado: (2022)

Neutralizing antibodies targeting SARS-CoV-2 spike protein
por: Xiaojie, Shi, et al.
Publicado: (2021)

Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike
por: Trigueiro-Louro, João, et al.
Publicado: (2020)

Secondary Structures of MERS-CoV, SARS-CoV, and SARS-CoV-2 Spike Proteins Revealed by Infrared Vibrational Spectroscopy
por: D’Arco, Annalisa, et al.
Publicado: (2023)

Structure-Based Design of Novel Peptidomimetics Targeting the SARS-CoV-2 Spike Protein
por: Alagumuthu, Manikandan, et al.
Publicado: (2020)

Spike Glycoprotein Is Central to Coronavirus Pathogenesis-Parallel Between m-CoV and SARS-CoV-2
por: Saadi, Fareeha, et al.
Publicado: (2021)

Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution
por: Zhang, Shuyuan, et al.
Publicado: (2021)

SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
por: Almehdi, Ahmed M., et al.
Publicado: (2021)

Structural and Immunoreactivity Properties of the SARS-CoV-2 Spike Protein upon the Development of an Inactivated Vaccine
por: Kordyukova, Larisa V., et al.
Publicado: (2023)

Structural diversity of the SARS-CoV-2 Omicron spike
por: Gobeil, Sophie M.-C., et al.
Publicado: (2022)

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
por: Hatmal, Ma’mon M., et al.
Publicado: (2020)

Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike
por: Crowley, Andrew R., et al.
Publicado: (2021)

Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
por: Crowley, Andrew R, et al.
Publicado: (2022)

Disulfide stabilization reveals conserved dynamic features between SARS-CoV-1 and SARS-CoV-2 spikes
por: Zhang, Xixi, et al.
Publicado: (2023)

Mutation profile of SARS-CoV-2 spike protein and identification of potential multiple epitopes within spike protein for vaccine development against SARS-CoV-2
por: Paul, Debadrita, et al.
Publicado: (2021)

Efficient disinfection of SARS-CoV-2-like coronavirus, pseudotyped SARS-CoV-2 and other coronaviruses using cold plasma induces spike protein damage
por: Qin, Hongbo, et al.
Publicado: (2022)

In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike Protein
por: Lin, Yu-Chao, et al.
Publicado: (2022)

Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals
por: Thébault, Stéphanie, et al.
Publicado: (2022)

Potential antiviral peptides targeting the SARS-CoV-2 spike protein
por: Khater, Ibrahim, et al.
Publicado: (2022)

Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection
por: Olukitibi, Titus A., et al.
Publicado: (2023)

Amyloidogenesis of SARS-CoV-2 Spike Protein
por: Nyström, Sofie, et al.
Publicado: (2022)

SARS-CoV-2 and the spike protein in endotheliopathy
por: Perico, Luca, et al.
Publicado: (2023)

Structural Biology of Nanobodies against the Spike Protein of SARS-CoV-2
por: Tang, Qilong, et al.
Publicado: (2021)

Structural Dynamics and Molecular Evolution of the SARS-CoV-2 Spike Protein
por: Wolf, Kyle A., et al.
Publicado: (2022)

The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2
por: Alluwaimi, Ahmed M., et al.
Publicado: (2020)

Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
por: Bangaru, Sandhya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mnbnaj59dhsp3c78n692m75rem